Australia
June 6, 2006
The Crop
Doctor, GRDC
The Crop
Doctor is GRDC Managing Director, Peter Reading
Biotechnology is being harnessed
in a project aimed at producing frost tolerant wheat and barley
varieties faster.
Working with 3000 wheat
varieties and 5000 barley varieties collected from an area
stretching from the Himalayas to the Middle East,
CSIRO Plant
Industry researcher Dr Ben Trevaskis is screening for variations
to the VRN1 gene, the one responsible for determining the
flowering date in wheat and barley. His project is supported by
growers and the Australian Government through
the Grains
Research and Development Corporation (GRDC).
Dr Trevaskis says there is an
enormous variation in alleles of the VRN1 gene. Initially the
gene is responsible for determining whether the wheat or barley
variety will flower in spring, or over-winter before flowering.
Breeders have been working with it for generations to make
selections for varying flowering times.
In fact, Dr Trevaskis says that
William James Farrer, developer of the Federation wheat variety
released in 1903, probably introduced the gene into Australia
when he was making his first crosses, while in the 1970s Dr
Albert Pugsley pioneered the work of introducing variations of
the gene into varieties with similar backgrounds. Dr Pugsley was
able to work with five different variations; however
developments in biotechnology are allowing researchers like Dr
Trevaskis to take using a diagnostic approach to identify more
variations from thousands of varieties.
Dr Trevaskis aims to produce
not only varieties with a range of flowering times but to make
use of another attribute of the gene, frost tolerance.
Breeding groups working to
identify vegetative traits responsible for frost tolerance have
traced them back to the VRN1 gene. Variations of this gene
influence not just the time of flowering, but frost tolerance.
It's natural - cereal varieties have developed in climates
ranging from extreme cold to extreme drought. Variations of this
gene are one of the critical factors in that acclimatisation. Dr
Trevaskis and his team aim to make selections leading to
varieties with a range of flowering times that are also frost
tolerant. It means that, even in high frost risk areas, growers
will be able to enjoy the flexibility of varieties with a range
of flowering times.
The key to this work is a
technique called 'eco-tilling'. In essence it means looking for
variations from the DNA sequencing of different varieties. Dr
Trevaskis says that we have already identified and understood
the properties of a large number of variations of the VRN1 gene
- he's looking for the as yet unidentified variations.
Screening 8,000 varieties is a
daunting task but modern technology will allow the team to
screen up to 100 varieties a day looking for those unidentified
variations.
Once isolated, the plan is to
introduce the selected alleles (variants) of the VRN1 gene into
a common parent that is an already established variety.
'Sunstate' has been chosen as the wheat variety and discussions
are still underway to identify suitable malting barley
varieties.
Dr Trevaskis says his team will
be able to turn this material over to plant breeders working in
the field so that they can see the effect of the variations in a
known variety under field conditions, and make their selections
from there. In effect they will have already completed about
half of the normal backcrossing needed to produce a new variety.
Better yet, Dr Trevaskis says
that it is possible to identify perfect markers associated with
selected variations. That will speed up the identification of
material containing the selected variations of the VRN1 gene.
The estimation is that initial
screening of the huge amount of collected material will take
three years and the incorporation of selected material into
existing varieties another two or three. It's a clear case of
biotechnology speeding the process of developing new and better
varieties through conventional methods and demonstrates the
GRDC's commitment to bring better varieties to growers faster.
For more information contact Dr
Ben Trevaskis on (02) 6246 5045 or email
ben.trevaskis@csiro.au
|